Ross Portaro - Venus Concept Executive Marketing
| VERO Stock | USD 2.68 0.57 17.54% |
Executive
Ross Portaro is Executive Marketing of Venus Concept
| Age | 61 |
| Phone | 877 848 8430 |
| Web | https://www.venus.ai |
Venus Concept Management Efficiency
The company has return on total asset (ROA) of (0.2055) % which means that it has lost $0.2055 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.6354) %, meaning that it created substantial loss on money invested by shareholders. Venus Concept's management efficiency ratios could be used to measure how well Venus Concept manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Indranil Dey | Bluejay Diagnostics | 62 | |
| Jennifer Englund | CVRx Inc | N/A | |
| Kelley Nicholas | Neuropace | N/A | |
| Isabelle Billet | Axogen Inc | 62 | |
| Robert Scott | Nuwellis | 44 | |
| Michael Donovan | Axogen Inc | 59 | |
| Jens Kemp | Axogen Inc | N/A | |
| Dylan John | Neuropace | N/A | |
| Ivica MD | Axogen Inc | N/A | |
| Vitaliy Epshteyn | Nuwellis | 46 | |
| Grgoire Ramade | Inogen Inc | 55 | |
| Adrien Mithalal | Inogen Inc | N/A | |
| Irina Ridley | Neuropace | 38 | |
| Ben Joseph | Anika Therapeutics | N/A | |
| Andres Cedron | Orthofix Medical | 44 | |
| Gretchen Strohminger | Accelerate Diagnostics | N/A | |
| FACC MBA | Nuwellis | N/A | |
| Harold Tamayo | Axogen Inc | N/A | |
| James Chase | Anika Therapeutics | N/A | |
| Tonya SPHR | CVRx Inc | 52 | |
| Katie Keller | Neuropace | N/A | |
Management Performance
| Return On Equity | -4.64 | ||||
| Return On Asset | -0.21 |
Venus Concept Leadership Team
Elected by the shareholders, the Venus Concept's board of directors comprises two types of representatives: Venus Concept inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Venus. The board's role is to monitor Venus Concept's management team and ensure that shareholders' interests are well served. Venus Concept's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Venus Concept's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anat Kotler, Head Management | ||
| Anna Georgiadis, Chief Officer | ||
| Jason Raser, Head USA | ||
| Hemanth CFA, President COO | ||
| Rajiv Silva, CEO Director | ||
| Kenji Shimizu, Interim Officer | ||
| Ross Portaro, Executive Marketing | ||
| Michael Mandarello, General Operations | ||
| Joyce Morris, Head Canada | ||
| Ognjen Petrovic, Robotics, RD | ||
| Melissa Kang, Chief Officer | ||
| Soren Sinay, Chief Officer | ||
| Yoni Iger, Head Affairs | ||
| Domenic CPA, Executive CFO | ||
| Domenic Penna, Chief Officer | ||
| William McGrail, Executive Compliance |
Venus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Venus Concept a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
When determining whether Venus Concept offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Venus Concept's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Venus Concept Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Venus Concept Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Venus Concept. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Venus Stock, please use our How to Invest in Venus Concept guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Venus Concept. If investors know Venus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Venus Concept listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Venus Concept is measured differently than its book value, which is the value of Venus that is recorded on the company's balance sheet. Investors also form their own opinion of Venus Concept's value that differs from its market value or its book value, called intrinsic value, which is Venus Concept's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Venus Concept's market value can be influenced by many factors that don't directly affect Venus Concept's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Venus Concept's value and its price as these two are different measures arrived at by different means. Investors typically determine if Venus Concept is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Venus Concept's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.